Biopolitical Times

The Center for Genetics and Society blog highlights the latest developments in the social, political, and ethical implications of human biotechnologies, with contributions from staff, fellows, consultants, and guest authors.

Subscribe


Claudine Gay at her Inauguration as Harvard President

Claudine Gay at her Inauguration as Harvard President
Charlotte Hysen/Governor's Press Office (CC BY-NC-SA 2.0)

On January 2, Claudine Gay, the first black President of Harvard (and only the second woman), resigned under pressure, barely six months after her appointment. Like the Presidents of Penn and MIT, she had been heavily criticized for not doing enough to combat antisemitism on campus, though that was not what forced her out. The New York Times headlined the story:

Harvard President...

Biopolitical Times

In a much-anticipated move, US regulators have approved two new gene therapies for sickle cell disease. On December 8, the Food and Drug Administration (FDA) gave the green light to Casgevy, a CRISPR-based therapy from Vertex Pharmaceuticals and CRISPR Therapeutics (co-founded by Emmanuelle Charpentier) and to Lyfgenia, a lentiviral-based gene therapy from bluebird bio that does not use gene editing.

Casgevy’s approval was the first in the US of a therapy using the CRISPR gene editing tool; it...

Throughout 2023, the Center for Genetics and Society stepped up its efforts to put social justice and human rights at the center of discussions about powerful new human biotechnologies. This push was reflected at the CGS blog Biopolitical Times in...

Risa Cromer’s Conceiving Christian America: Embryo Adoption and Reproductive Politics richly contextualizes embryo adoption programs within the growth and evolution of the conservative Christian Right. Drawing on 27 months of fieldwork, primarily conducted at embryo adoption programs and secondarily at...